Caprylic Triglyceride CAS: 73398-61-5
Related Insights
China's Aromatics and Alcohol Price Surge: Understanding the July 1 Petrochemical Repricing Wave
Chinese refining and chemical producers sharply increased price quotations for aromatics and alcohols on July 1, 2026, creating fresh challenges for downstream manufacturers and procurement teams. Buyers should understand what triggered the repricing wave and how it may influence future sourcing strategies.
Jordan API Supply: Post-Crisis Recovery Assessment for Antibiotic Procurement Teams
Jordan's pharmaceutical API exports are showing signs of recovery as regional shipping conditions improve. Buyers dependent on antibiotic APIs should use July to verify logistics, rebuild inventories and secure Q3 supply agreements. This guide evaluates logistics recovery, procurement risks and outlines actionable Q3 sourcing strategies.
Iran's 69% Inflation Rate: What It Means for Pharmaceutical Chemical Trade Through Hormuz
Iran's projected 69% inflation rate is reshaping pharmaceutical chemical trade across the Middle East. While Iranian petrochemical producers remain cost-competitive, ongoing sanctions, export restrictions, and shipping uncertainty continue to create challenges for pharmaceutical solvent procurement.
Iran’s IRGC Attacks Prompt Redefinition of Chemical Supply Chains
The IRGC’s recent strikes on the "Ever Lovely" and "Kiku" tankers expose a stark contradiction between Iran’s foreign ministry and its armed forces. This internal conflict forces global chemical buyers to reassess the safety and legality of sourcing from Iranian petrochemicals amid shifting export waivers and maritime threats.
Ras Tanura Restart Fuels Q3 Export Surge for Saudi Chemical Industry
After months of disruption, the Ras Tanura terminal has officially resumed operations, marking a pivotal moment for Saudi Arabia’s chemical export landscape. Trading Economics data now shows Gulf chemical exports climbing to 75% of pre‑war levels, a clear signal that supply chains are tightening and demand is returning.
Pharmaceutical Chemical Procurement Intelligence: June 24, 2026 Situation Report
Pharmaceutical procurement teams face an unusually complex H2 2026 environment shaped by GLP-1 manufacturing demand, excipient compliance changes, freight cost shifts, regulatory deadlines, and elevated drug shortage risk across critical therapeutic categories.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.